From January 1, 2024 to March 18, 2024, the company has repurchased 245,800 shares, representing 0.55% for ¥803.39 million. With this, the company has completed the repurchase of 1,909,900 shares, representing 4.18% for ¥5,999.99 million under the buyback announced on May 8, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,190 JPY | +1.43% | +1.75% | +3.24% |
May. 08 | Japanese Shares Swing to Red Amid Profit-Taking, US Rate Cut Uncertainty | MT |
May. 08 | Kissei Pharmaceutical's Attributable Profit Jumps 6% in Fiscal 2023; Shares Tumble 11% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.24% | 884M | |
+15.54% | 78.51B | |
+12.87% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 4547 Stock
- News Kissei Pharmaceutical Co., Ltd.
- Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.